A Case Report of Successful Management of Thrombotic Thrombocytopenic Purpura Syndrome (TTP) in a Pregnant Woman with Plasmapheresis

Authors

  • rezagholi, payman Department of Operating Room, Faculty of Nursing and Midwifery, Kurdistan University of Medical Sciences, Sanandaj, Iran
Abstract:

Background and Aim: Thrombotic thrombocytopenic purpura is a rare and life-threatening disease with a relatively high prevalence of 5% in pregnancy that causes thrombocytopenia. Due to the high prevalence and mortality of fetal and maternal mortality, which resolves rapidly with the onset of plasmapheresis, the diagnosis of this disease is clinically important. The aim of this study was to successfully manage thrombotic thrombocytopenic purpura syndrome (TTP) with plasmapheresis in pregnant women. Case Report: The patient was a 29-year-old woman who was admitted at 21 weeks’ gestation and second pregnancy with fever, muscle aches, increased liver enzymes, headache, decreased consciousness and hallucinations. Due to the low pH and high lactic acid dehydrogenase and neurological symptoms and fever, TTP was diagnosed for the patient and started with 15 units of freshly frozen plasma daily plasma milling until normalization of lactic acid dehydrogenase and platelets. He was discharged in good general condition. Discussion and Conclusion: TTP should be considered in the differential diagnosis of missed pregnancies in the second trimester of pregnancy and pregnancies with thrombotic microangiopathy and reduced ADAMTS13 activity should be considered. Although TTP is a deadly disease without treatment, most patients recover with plasmapheresis, so it is recommended to start plasmapheresis as soon as there is clinical doubt based on the patient's tests and symptoms.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Plasmapheresis in thrombotic thrombocytopenic purpura (TTP)

A 70-year-old woman with thrombotic thrombocytopenic purpura (TTP) was treated with plasmapheresis using fresh frozen plasma as a fluid replacement. Complete recovery and lasting remission were observed. It appears that plasmapheresis combined with massive fresh frozen plasma can be an effective mode of treatment for patients who were, otherwise, refractory to conventional therapy.

full text

Successful Treatment of Refractory Thrombotic Thrombocytopenic Purpura with Rituximab, a Monoclonal Antibody: a Case Report

Thrombotic thrombocytopenic purpura (TTP) is mostly attributed to the presence of an autoantibody against ADAMTS-13, a metalloprotease that degrades ultralarge von Willebrand protein multimers. Accumulation of vWF multimers and systemic platelet aggregation lead to microangiopathic thrombosis, hemolytic anemia, and end-organ ischemia. Most patients respond to therapeutic plasma exchange (TPE), ...

full text

Successful treatment of thrombotic thrombocytopenic purpura during pregnancy: A case report

A 28 years’ pregnant woman with 24 weeks’ gestational age referred with petechiae and purpura from previous day without any trauma. She had an occipital headache from last night. Overt petechial and purpuric lesions were seen in the mouth and skin. There was neither hepatosplenomegaly nor lymphadenopathy. She was conscious and oriented. The patient was febrile, anemic and thromboc...

full text

A case of Acquired Thrombotic Thrombocytopenic Purpura without Renal Dysfunction

Objective: Thrombotic thrombocytopenic purpura (TTP) is the most malignant variant of microangiopathy that usually presents by typical symptoms including thrombocytopenia, hemolytic anemia, neurological abnormalities, fever and renal impairment. Report of the Case: We report a 12-year-old male presented by cytopenia, fever, purpura on his extremities, seizure and lethargy. Peripheral blood sm...

full text

Thrombotic thrombocytopenic purpura, a case report.

We report a case of thrombotic thrombocytopenic purpura (TTP) in a 60 years-old woman with Sjogren's syndrome. Symptomatology on admission leads to evoke the diagnosis of TTP. Biological results allow to set the diagnosis. Actually, association of haemolytic anaemia, schizocytes and thrombocytopenia are in favour of TTP. Undetectable ADAMTS 13 activity (below 5%) confirms the diagnosis. In cong...

full text

Ipilimumab-induced thrombotic thrombocytopenic purpura (TTP)

BACKGROUND CTLA-4 (Cytotoxic T-lymphocyte-associated protein 4) was the first immune checkpoint receptor clinically targeted for use in cancer treatment. It is expressed exclusively on T-cells where its primary role is to regulate the amplitude of the early stages of T-cell activation.1 Ipilimumab, a CTLA-4 blocking antibody, has been widely used for the treatment of patients with high risk and...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 23  issue None

pages  99- 104

publication date 2021-04

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

No Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023